Ligand Pharmaceuticals reported $821.63M in Equity Capital and Reserves for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Arrowhead Research ARWR:US $ 452.27M 79.71M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
Immunogen IMGN:US $ 306.47M 19.12M
Intrexon XON:US $ 131.25M 27.95M
IONIS PHARMACEUT IONS:US $ 772M 241.46M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M
Spectrum Pharmaceuticals SPPI:US $ 55.26M 7.7M